Hormonal receptors in mammary carcinoma
comparison between quantitative and qualitative methods
Palavras-chave:
Breast carcinoma, Prognosis, Hormonal receptors assays, Correlation of methodsResumo
À tradicional dosagem dos receptores hormonais para avaliação prognóstica e abordagem clínica no câncer de mama, métodos alternativos para determinação imunohistoquímica vêm sendo propostos. Com finalidade comparativa, tais procedimentos foram correlacionados em 37 pacientes exibindo 5 a 15 anos de sobrevida. Tomando como índice de positividade 30 fm/mg a discordância entre os métodos alcançou 35,1% com os estrógenos e 48,5% com os receptores de progesterona, Quando o nível de positividade foi alterado para 20 fm/mg o desencontro de resultados reduziu-se para 32% com o ER, elevando-se para 57% com o PgR. Este estudo nos permitiu concluir pela não recomendação do método imunohistoquimico com laminas fixadas em parafina, como um procedimento alternativo à dosagem com carvão-dextrã, para prognóstico e abordagem terapêutica no carcinoma mamário.
Downloads
Referências
Schinzinger: Chir Congress 1:28-29,1889 In: Juret P. Endocrine surgery in human cancers. Springfield. CR Thomas Publisher. 1966:7
Beatson GT: On treatment of operable cases in carcinoma of mamma: suggestion for a new method of treatment with illustrative cases. Lancet 1896;2:104-7
Jensen EV: Estrogen receptors in hormone-dependent breast cancers. Cancer Res 1975;35:3362-4
McGuire WL: Value of steroid receptors assays in the management of patients with breast cancer. Breast 1978;4:3-6
Montoro AF: A importancia clinica dos receptores hormonais no carcinoma mamario. Rev Bras Ginec Obstet 1981;3:20-5
Jensen EV: Personal communication
Pertschuk LP:Tobin EH et al: Immunofluorescent detection of estrogen receptors in breast cancer. Cancer 1978; 41:907-11
Montoro AF;Rivera JS & Montoro FF: Receptores hormonais e manipulação endócrina. Femina 1993;21:816-25
Osborne CK: Receptors. In: Harvis JR,Helmann S,Henderson IC & Kinne DW. Breast Diseases. Philadelphia: JBLippincott Co 1991:301
King WJ; De Sombre ER; Jensen EV & Greene GL: Comparison of Immunocyto-chemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res 1985;45:293-304
Miller RT;Hapke MR & Greene GL: Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P routinely processed formaldehyde fixed breast tissue. Cancer 1993;71:3541-6
Sklarew RJ;Bodmer SC & Pertschuk LP: Quantitative imaging of immunocyto-chemical estrogen receptor staining patterns in breast cancer sections. Cytometry 1990;11:359-78
anssens JP; Pylyser K et al: Biochemical and histochemical analysis of steroid hormone binding sites in human primary breast cancer. Cancer 1985;55:2600-11
Pertschuk LP; Eisemberg KB; Carter AC & Feldmann JG: Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response. Cancer 1985;55:1513-8
Leal SN;Rosen L; Frank B & Poppiti Jr RJ: Comparison of estrogen receptor determination using the estrogen receptor immunocytochemical assay in 85 human breast carcinomas. Breast Dis 1989;1:243-51
Panko WB; Mattioli CA & Wheeler TM: Lack of correlation of a histochemical method of estrogen receptor analysis with biochemical assay results. Cancer 1982; 49:2148-52
Osborne CK: Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Seminars in Oncology 1985;12:317-26
Borjesson BW; Canchi MN et al: Sources of improvement between laboratory variation in estrogen and progestin receptor measurements using samples during the Australasian quality assurance programme. Eur J Cancer Clin Oncol 1989; 25:1087-93
Thorpe SM; Poulsen HS; Pederson KO & Rose C: Impact of standardization of estrogen and progesterone receptors assays of breast cancer biopsies in Denmark. Eur J Cancer Clin Oncol 1988:24:1263-9
Ozzello L; De Rosa C; Habif DV & Greene GL: An immunohistochemical evaluation of progesterone receptor in frozen section, paraffin sections and cytologic imprints of breast carcinomas. Cancer 1991; 67:455-62
Parl FF & Posey YF: Discrepancies of the biochemical and immunohistochemical estrogen receptors assays in breast cancer. Human Pathol 1988:19:960-6
Kinsel B; Szabo E et al: Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative bio-chemical methods. Cancer Res 1989;49:1052-6
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.